Cargando…
Zika Virus-Specific IgY Results Are Therapeutic Following a Lethal Zika Virus Challenge without Inducing Antibody-Dependent Enhancement
The Zika virus (ZIKV) is a newly emerged pathogen in the Western hemisphere. It was declared a global health emergency by the World Health Organization in 2016. There have been 223,477 confirmed cases, including 3720 congenital syndrome cases since 2015. ZIKV infection symptoms range from asymptomat...
Autores principales: | O’Donnell, Kyle L., Meberg, Bernadette, Schiltz, James, Nilles, Matthew L., Bradley, David S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6466411/ https://www.ncbi.nlm.nih.gov/pubmed/30917523 http://dx.doi.org/10.3390/v11030301 |
Ejemplares similares
-
Dengue virus specific IgY provides protection following lethal dengue virus challenge and is neutralizing in the absence of inducing antibody dependent enhancement
por: Fink, Ashley L., et al.
Publicado: (2017) -
Human Polyclonal Antibodies Prevent Lethal Zika Virus Infection in Mice
por: Branche, Emilie, et al.
Publicado: (2019) -
Zika virus challenges for neuropsychiatry
por: Simões e Silva, Ana Cristina, et al.
Publicado: (2016) -
Preschool Neurodevelopment in Zika Virus-Exposed Children Without Congenital Zika Syndrome
por: Mulkey, Sarah B., et al.
Publicado: (2023) -
A VSV-based Zika virus vaccine protects mice from lethal challenge
por: Emanuel, Jackson, et al.
Publicado: (2018)